APA

Wentink M. Q., Verheul H. M. W., Pal S. K., George S., Voortman J., Danchaivijitr P., Adelaiye R., Poslinski D., Groman A., Hutson A. & Pili R. (2017). Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma. : Clinical genitourinary cancer.

Chicago

Wentink Madelon Q, Verheul Henk M W, Pal Sumanta K, George Saby, Voortman Johannes, Danchaivijitr Pongwut, Adelaiye Remi, Poslinski Diane, Groman Adrienne, Hutson Alan and Pili Roberto. 2017. Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma. : Clinical genitourinary cancer.

Harvard

Wentink M. Q., Verheul H. M. W., Pal S. K., George S., Voortman J., Danchaivijitr P., Adelaiye R., Poslinski D., Groman A., Hutson A. and Pili R. (2017). Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma. : Clinical genitourinary cancer.

MLA

Wentink Madelon Q, Verheul Henk M W, Pal Sumanta K, George Saby, Voortman Johannes, Danchaivijitr Pongwut, Adelaiye Remi, Poslinski Diane, Groman Adrienne, Hutson Alan and Pili Roberto. Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma. : Clinical genitourinary cancer. 2017.